Motus GI released its third quarter 2018 financial results, posting a $5.2 million net loss, or a $0.33 loss per diluted share.
Here's what you should know:
1. Year to date, Motus GI reported $16.7 million in net losses, totaling a $1.13 loss per share.
2. Despite the losses, Motus has $11.6 million in cash and short-term investments.
3. Motus is readying for the commercial launch of its colonoscopy preparing Pure-Vu System in 2019.
4. Motus GI CEO Tim Moran said, "We have made significant progress in recent months to ensure the company is positioned for a successful commercial launch of the Pure-Vu System in 2019."
5. Motus appointed Mr. Moran as CEO during the third quarter. Former CEO Mark Pomeranz will continue serving as the company's president and COO.